Sangamo Therapeutics
SGMO
SGMO
193 hedge funds and large institutions have $679M invested in Sangamo Therapeutics in 2021 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 59 increasing their positions, 65 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
2% less funds holding
Funds holding: 197 → 193 (-4)
25% less capital invested
Capital invested by funds: $911M → $679M (-$232M)
Holders
193
Holding in Top 10
–
Calls
$10M
Puts
$7.84M
Top Buyers
| 1 | +$13.6M | |
| 2 | +$4.95M | |
| 3 | +$3.17M | |
| 4 |
LOAMS
Lombard Odier Asset Management (Switzerland)
Petit-Lancy,
Switzerland
|
+$1.83M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$1.57M |
Top Sellers
| 1 | -$11.3M | |
| 2 | -$6.58M | |
| 3 | -$6.38M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$6.22M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$3.56M |